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Dear Sirs,
The Global Alliance against Respiratory Diseases (GARD) is a network
within the  World Health Organization (WHO), comprising
representatives of national and international organisations,
institutions and agencies, all of whom are working towards the
common goal of improving global lung health.1-3 GARD aims to
increase worldwide recognition of the importance of Chronic
Respiratory Diseases (CRDs) as one of the most important health
problems globally, and also aims to establish cooperation between
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countries and GARD member organisations in improving
programmes for the prevention and management of CRDs.2,3
GARD was formed almost a decade ago, and since then there
have been many successes, particularly at country level (see Table 1).
There has indeed been increased recognition of the importance of
chronic diseases, as demonstrated by the United Nations Summit on
Chronic Diseases held in  2012, during which CRDs – along with
cardiovascular diseases, diabetes and cancers – were recognised as
major priorities. 
However, in many countries there has been reluctance to
engage with local GARD champions in establishing local initiatives.
One reason for this is a preference for national health services to
devise strategies that include other chronic diseases, and in many
countries there appears to be a lack of political will to commit to
effective CRD prevention and control measures. Nevertheless, local
GARD champions – many of whom are national and international
leaders in respiratory and allergic disease professional medical
societies – continue to be key activists for the formation of effective
programmes.
Current projects vary in different countries according to
country-specific needs and the level of engagement of government
health departments. Where government involvement is strong, as in
Turkey, Italy and Portugal,4-6 progress has been considerable. In Italy,
Portugal, Kyrgyzstan, Russia and Turkey, GARD has played a
significant role in assisting the development of national CRD control
programmes. However, in other countries the GARD-supported
programmes are more limited, being either disease-specific or
restricted to certain geographical regions. In 2012, GARD played an
important role in helping to establish the Portuguese National
Programme on Respiratory Diseases.6 The Dutch GARD leadership
succeeded in convincing the government to develop a SMART-
formulated collaborative National Action Programme on CRDs.7 In
the Czech Republic, GARD leaders launched CARO (Czech Alliance
against Chronic Respiratory Diseases), leading to the formation of a
National Programme by the Ministry of Health in 2008. GARD Brazil
has made significant strides in including a guideline for prevention
and management of asthma, rhinitis and COPD in primary health
care programmes, and has implemented  a pilot project utilising  the
Practical Approach to Lung Health (PAL); in addition, access to free
inhalers for patients with asthma has increased throughout the
country.8
GARD has four strategic objectives: advocacy; partnership;
national plans; and surveillance. For each objective, expected
outcomes, indicators, milestones and core activities have been
established.
Advocacy 
The majority of countries have focal points within their
governmental health departments, usually the officer in the health
ministry responsible for NCDs. Obtaining and maintaining ongoing
ministerial endorsement is a problem in some countries since
governments can change frequently and rapidly, causing changes in
health policy and national priorities.
Partnership
GARD’s policy is to develop and maintain a  network of collaborative
partnerships with different parties, which then helps with both
human and financial resources. The number of collaborating parties
in different countries varies, and is highest in  Turkey (58 parties),
Italy (42), the Netherlands (34), Czech Republic (21), Portugal (18),
Iran (13) and Krygyzstan (12). Funding models also vary. In Turkey
and Italy, GARD projects are funded by the Ministry of Health, and
in the Netherlands there is substantial government funding. In most
other countries, GARD activities are funded by a variety of sources
including non-governmental organisations (NGOs), pharmaceutical
companies and the private sector.
National plans
The expected outcome for national plans is a strengthening of
existing initiatives for CRDs and the adoption of  multisector
national policies which conform to the WHO Action Plan for NCDs
(see Table 1). GARD Turkey is a good example of this integration.9
In Turkey’s national plans, not only were CRDs included in the NCD
plans,  but the GARD-affiliated  CRD experts led the development
of an NCD network that established the national plan. In Italy,
planning innovation required confrontation of  issues that threaten
public health.4 In the Netherlands, their national programme aims
to reduce hospitalisation days, productivity loss, adolescent
smoking, and mortality due to asthma and COPD.7 South Africa’s
plan included development of an integrated care clinical practice
guideline for asthma, COPD, TB and pneumonia, as well as a
training programme for  primary care nurses and doctors; initially
called Practical Approach to Lung Health South Africa (PALSA
PLUS), the South African programme is now called PC101 and has
been adopted by the Ministry of Health for national roll-out.10
Integrated Care Pathways for Airway Diseases (AIRWAYS-ICPs) is a
GARD demonstration project approved by the European
innovation Partnership on Active and Healthy Ageing (DG Sanco
and CNECT, European Union).
Surveillance
Expected outcomes are the development of a WHO framework for
evaluating CRDs, collection of epidemiological information,
identification of knowledge gaps, and the development of cost-
effective interventions.2 A further outcome is the proportion of
participating countries whose information on CRDs is reported to
WHO and subsequently published. Using national ministry of health
data, information and analysis from two countries, Turkey5,9 and
Italy4, has already been published.
To date, GARD’s major achievements have been the launch of
national GARD-led initiatives and a variety of projects in partnership
with government health departments, as exemplified by GARD’s role
in Turkey, Portugal  and Italy. Arguably, GARD’s greatest
achievement has been its ability to forge collaborative partnerships
and develop a shared vision with a large number of parties including
professional medical societies, patient organisations, medical and
pharmaceutical companies, NGOs, governments, and WHO, in
order to address chronic respiratory diseases and allergy worldwide.
Preventing and controlling CRDs, and keeping them on the global
health agenda, will require the ongoing energies of all involved in
GARD. 
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COUNTRY GARD COUNTRY PLANS
BRASIL8 Persuade health authorities in all levels (country, provinciale and municipal) to plan and  implement a CRDs program in collaboration 
with local  stakeholders 
CZECH REPUBLIC Support co-operation between pneumologists and allergologists;
Organize international events on CRD (for example, World Spirometry Day)
Increase patient education (CARO launched a publication on  respiratory disorders for patients) 
CHINA Encourage educational activities for doctors, patients and the wider community 
Establishment of an e-medicine service
Arrange congresses and seminars for respiratory physicians
EGYPT Undertake studies on the prevelance of COPD in Egypt
Implement guidelines for the diagnosis and management of COPD including campaigns for tobacco control  
IRAN Plans to assess the current status for NCD/CRDs before developing a programme 
ITALY4 Promotion of lung health and raising the level of public awareness on respiratory hazards. Several other initiatives have begun.
KYRGYZSTAN The GARD National Action Plan  2008-2012 was developed and published in the Official Journal of the Euro-Asian Respiratory Society 
"Respiratory Medicine" and a report has been presented to the Ministry of Health.
The integrated plan for prevention and control of CRD by the MoH 2013-2016  in development with  participation by the Deputy Minister 
of Health. This will be integrated into the National Program of control of NCD 2013-2016.
NETHERLANDS7 Dutch National Action Programme on Chronic Lung Diseases: Objectives are to achieve the following;
1)  25% reduction in hospitalisation days for asthma and COPD
2)  15% reduction in lost working days due to asthma and COPD
3)  20% improved cost-effectiveness of inhalation medication
4)  25% reduction of adolescents taking up smoking
5)  10% reduction of mortality due to asthma and COPD
PAKISTAN 1GARD Projects include 1. A study of Airborne Allergens in Islamabad & Rawalpindi. 2. Free Pollen Allergy Camp in Islamabad, with Chief 
Commissioner, Islamabad Capital Territory. 3. Training of Primary Care Physicians in Allergy & Asthma Management. 4. National Aeroallergen 
Study
POLAND National Programme of Early Diagnostics and Treatment of Asthma “POLASTMA”
PORTUGAL6 During the first years, 2007-2011, the major aim of GARD  was the integration, participation and dissemination of activities from 
governamental and non-governamental organizations (18) linked to CRD. Since  2012 GARD has been part of the new National 
Programme on Respiratory Diseases supported by the MoH. 
ROMANIA GARD initiatives are;
1.  Study the prevalence of COPD
2.  Organise training courses in somnology, smoking cessation, functional testing 
3.  Provide e-learning training on 8 hot topics including chronic obstructive diseases 
4.  Provide  courses on the Romanian Society of Pneumology-on Update GOLD
5.  Perform studies to determine the national prevalence of 
6.  Perform studies on compliance of patients with COPD Management - COPD360
SOUTH AFRICA Adaptation and nationwide implementation of the Practical Approach to Lung Health in South Africa (PALSA Plus) and Primary Care 101 
(PC101) in all DOH primary care facilities 
TURKEY5 GARD Turkey Project (National control program and action plan on Chronic Airway Diseases (Asthma & COPD)
1.  Monitor these diseases and the control program 
2.  Perform studies for awareness and advocacy
3.  Peform activities for prevention of the development of disease
4.  Perform activities for early detection and prevention of progress
5.  Provide effective treatment and prevent complications
VIETNAM Expansion of the asthma and COPD outpatient care units to the whole country
Table 1. GARD Country Plans
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